1887

Abstract

We evaluated the automated VITEK 2 system (bioMérieux) for antimicrobial susceptibility testing of vancomycin-resistant (VRE). The results obtained with the VITEK 2 system were compared to those obtained using two NCCLS reference methods. The VITEK 2 system produced MICs for penicillin G, erythromycin and vancomycin that were very similar to those of the reference agar-dilution test with all results being within a twofold dilution. When MICs of teicoplanin for these isolates were measured by the agar-dilution method and VITEK 2 system, there was one ‘very major’ error and seven ‘minor’ errors. There were no ‘major’ errors for any of the antibiotics tested. When the results obtained by the micro broth-dilution method were compared with those obtained by the VITEK 2 system, there was one ‘very major’ error for teicoplanin by the VITEK 2 system, as was the case with the agar-dilution method. There were two ‘minor’ errors for erythromycin and seven ‘minor’ errors for teicoplanin. There were no ‘major’ errors for any of the antibiotics tested. The 35 VRE strains identified phenotypically by the VITEK 2 Advanced Expert System included nine of and 23 of . Neither nor were identified. A total of 32 phenotypes were classified into 22 VanA and 10 VanB strains. PCR genotyping demonstrated 23 and nine strains. There were differences between the VITEK 2 system results and those of PCR. Overall, 54.3 % of the test results were obtained within 7 h. All MIC values for the 35 VRE isolates were determined within 13 h of completing incubation. The VITEK 2 system is a simple method for accurately detecting vancomycin-resistant strains of and can be used to rapidly determine MICs.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45765-0
2004-12-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/12/JM531209.html?itemId=/content/journal/jmm/10.1099/jmm.0.45765-0&mimeType=html&fmt=ahah

References

  1. CDC ( 1993;). Nosocomial enterococci resistant to vancomycin – United States, 1989–1993. Morb Mortal Wkly Rep 42, 597–599.
    [Google Scholar]
  2. Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M. & Tenover, F. C. ( 1993;). Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 37, 2311–2317.[CrossRef]
    [Google Scholar]
  3. Fines, M., Perichon, B., Reynolds, P., Sahm, D. F. & Courvalin, P. ( 1999;). VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43, 2161–2164.
    [Google Scholar]
  4. French, G. L. ( 1998;). Enterococci and vancomycin resistance. Clin Infect Dis 27 (Suppl. 1), S75–S83.[CrossRef]
    [Google Scholar]
  5. Funke, G., Monnet, D., deBernardis, C., von Graevenitz, A. & Freney, J. ( 1998;). Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 36, 1948–1952.
    [Google Scholar]
  6. Garcia-Garrote, F., Cercenado, E. & Bouza, E. ( 2000;). Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol 38, 2108–2111.
    [Google Scholar]
  7. Jochimsen, E. M., Fish, L., Manning, K., Young, S., Singer, D. A., Baker, R., Jarvis, W. R. ( 1999;). Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting. Infect Control Hosp Epidemiol 20, 106–109.[CrossRef]
    [Google Scholar]
  8. Murray, B. E. ( 1995;). What can we do about vancomycin-resistant enterococci? Clin Infect Dis 20, 1134–1136.[CrossRef]
    [Google Scholar]
  9. NCCLS ( 2000a). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th edn. NCCLS document M7-A5. Villanova, PA: National Committee for Clinical Laboratory Standards.
  10. NCCLS ( 2000b). Performance standards for antimicrobial susceptibility testing. Tenth informational supplement (aerobic dilution), M100-S10. Villanova, PA: National Committee for Clinical Laboratory Standards.
  11. Perichon, B., Reynolds, P. & Courvalin, P. ( 1997;). VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 41, 2016–2018.
    [Google Scholar]
  12. Sahm, D. F. & Olsen, L. ( 1990;). In vitro detection of enterococcal vancomycin resistance. Antimicrob Agents Chemother 34, 1846–1848.[CrossRef]
    [Google Scholar]
  13. Saraiva, I. H., Jones, R. N., Erwin, M. & Sader, H. S. ( 1997;). Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci. Rev Assoc Med Bras 43, 217–222 (in Portuguese).
    [Google Scholar]
  14. Tokars, J. I., Satake, S., Rimland, D. & 8 other authors ( 1999;). The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans’ Affairs institution. Infect Control Hosp Epidemiol 20, 171–175.[CrossRef]
    [Google Scholar]
  15. van den Braak, N., Goessens, W., van Belkum, A., Verbrugh, H. A. & Endtz, H. P. ( 2001;). Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J Clin Microbiol 39, 351–353.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45765-0
Loading
/content/journal/jmm/10.1099/jmm.0.45765-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error